Home > Financial Ratios > STRIDES PHARMA SCIENCE

STRIDES PHARMA SCIENCE
Core EBITDA Margin

    Back to All Ratios
STRIDES PHARMA SCIENCE is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for STRIDES PHARMA SCIENCE
Please provide your vote to see the results

STRIDES PHARMA SCIENCE Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Margin(%) 11.259.406.17-0.4011.45

What is the latest Core EBITDA Margin ratio of STRIDES PHARMA SCIENCE ?

The latest Core EBITDA Margin ratio of STRIDES PHARMA SCIENCE is 11.25 based on Mar2025 Consolidated results.
Year Core EBITDA Margin
Mar202511.25
Mar20249.40
Mar20236.17
Mar2022-0.40
Mar202111.45

How is Core EBITDA Margin of STRIDES PHARMA SCIENCE Trending?

Years Core EBITDA Margin % Change
Mar2025 11.25
19.68
Mar2024 9.4
52.35
Mar2023 6.17
Positive
Mar2022 -0.4
Negative
Mar2021 11.45 -

Other Financial Ratios of STRIDES PHARMA SCIENCE


Compare Core EBITDA Margin ratio of peers of STRIDES PHARMA SCIENCE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
STRIDES PHARMA SCIENCE ₹8,730.9 Cr 1.2% 13.8% -38.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,147.0 Cr 0.2% 2.3% -9.3% Stock Analytics
DIVIS LABORATORIES ₹176,708.0 Cr -1.3% 9.1% 16.7% Stock Analytics
CIPLA ₹121,525.0 Cr 0.2% -0.6% -3.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,147.0 Cr 0.6% 1% 10.8% Stock Analytics
DR REDDYS LABORATORIES ₹100,596.0 Cr 0.6% -3.5% -4.3% Stock Analytics


STRIDES PHARMA SCIENCE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
STRIDES PHARMA SCIENCE

1.2%

13.8%

-38.7%

SENSEX

-1.4%

1.7%

4.8%


You may also like the below Video Courses